Sage gets U.S. approval for first postpartum depression therapy

Sage gets U.S. approval for first postpartum depression therapy



The U.S. Food and Drug Administration on Tuesday approved Sage Therapeutics Inc’s drug for postpartum depression, marking the first approval of a treatment specifically developed for the condition that affects a new mother’s ability to care for herself or her baby.





Source link